Merit Medical Receives FDA 510(k) Clearance for SCOUT MD Surgical Guidance System
Merit Medical Systems Inc, a leading manufacturer of medical devices, has recently announced that it has received FDA 510(k) clearance for its SCOUT MD Surgical Guidance System. This new guidance system is seen as a significant advancement in breast cancer care, as it allows for the precise excision of tumors by targeting their location in multiple dimensions. The SCOUT MD Surgical Guidance System aims to ensure successful surgeries and improve patient outcomes.
The SCOUT MD Surgical Guidance System provides surgeons with real-time, intraoperative 3D information that assists in identifying the precise location of target tissues. This helps surgeons to more accurately plan and execute the removal of tumors during breast cancer surgeries. The system works by using a reflector that is placed in the breast tissue prior to surgery. The reflector can then be easily tracked using the SCOUT console, providing continuous guidance and feedback to the surgeon.
This advancement in breast cancer care is expected to greatly benefit patients by reducing the need for multiple surgeries. By accurately locating tumors and guiding surgeons during excision, the SCOUT MD Surgical Guidance System aims to minimize the risk of leaving any cancerous tissue behind. This can help reduce the need for reoperations and improve overall surgical outcomes.
The recent FDA 510(k) clearance marks an important milestone for Merit Medical Systems Inc. It showcases the company’s commitment to innovation and its dedication to improving patient care in the field of breast cancer treatment. With this clearance, Merit Medical can now proceed with the commercialization of the SCOUT MD Surgical Guidance System in the United States. By bringing this advanced technology to the market, the company aims to provide surgeons with a valuable tool that can enhance their ability to perform successful and precise breast cancer surgeries.
Comments